U.S. Residential REITs Stock News

Reinsurance Group of America (RGA) has drawn fresh attention after reporting second quarter 2026 results that included higher revenue, higher net income, and increased earnings per share from continuing operations compared with a year earlier. See our latest analysis for Reinsurance Group of America. The strong Q2 2026 update, higher quarterly dividend, and recent share buybacks appear to sit alongside firm price momentum, with Reinsurance Group of America posting a 17.6% 90 day share price...

Why Allison Transmission Holdings Stock Is Back In Focus Allison Transmission Holdings (ALSN) is back on investors' radar after second quarter 2026 results showed record quarterly sales, new defense contracts, and higher full year guidance following its off highway business integration. The company reported second quarter sales of US$1,566 million compared with US$814 million a year earlier, supported by defense orders including a US$250 million 4040 MX transmission contract and programs for...

Viant Technology just watched its stock drop 6.4% to US$13.19, even though the quarter delivered the kind of numbers many ad tech investors say they want. Revenue for this programmatic advertising platform reached US$104.3m in Q2 2026 and adjusted EBITDA came in at US$14.2m, both ahead of what the company had guided only a few months ago. The market focused on the headline price move. The earnings story centered on strong contribution ex traffic acquisition costs and expanding profitability...

Upwork stock just absorbed a sharp 15% hit in a single session, even though the company reported one of its cleanest profitability stories to date. The freelance marketplace closed at US$8.36 after the Q2 report. Adjusted EBITDA reached US$64.1m with a 33.4% margin, which was above guidance and near the top of what investors usually expect for this business model. The market is focused on slowing revenue guidance and platform headwinds. The headline from this quarter is different, as Upwork...

Franklin Financial Services stock edged up about 2% today, yet the real story sits inside the bank’s margin engine. Quarterly net interest margin held at 3.5% while earnings per share landed at about US$1.47, keeping profitability in focus even as revenue for the quarter stood near US$22.9m. For a stock trading on an 11.5x P/E with a 2.15% dividend yield, this report is less about a one day bounce and more about whether that margin strength can continue to support the investment case. Is...

Carlyle Group stock edged up about 1.2% to US$48.36 after earnings, which is a modest move for a quarter that put the spotlight squarely on profit pressure. The long term pitch on Carlyle is a global alternative asset manager with strong fee power and fundraising momentum. This quarter the headline story is much more about the squeeze in earnings and margins that now sits behind that story. Basic earnings per share for Q2 landed at about US$0.38 on revenue of US$922 million, with trailing net...

International Money Express came into this quarter on the back foot. The stock has slipped about 23% over the past three months and eased another 1.7% today, even after the fresh earnings release. The headline is not revenue growth. The story is profit pressure. Trailing net margin has compressed to 4.3% from 8.6% a year earlier, and the latest 12 months include a sizeable one off loss of about US$12.1 million. For a remittance focused payments company that usually lives or dies on spread and...

NIQ Global Intelligence stock rose 41.9% to US$16.58 on Tuesday, a move that indicates traders liked what they saw in the Q2 print. The headline is simple: adjusted earnings per share came in at US$0.27 and adjusted earnings before interest, tax, depreciation and amortization margin reached 23.3%, while levered free cash flow turned positive at US$74.1m. In the short term, the market is reacting to that profitability and cash story. Over the longer term, the key issue is how sustainable that...

Ardelyx (ARDX) is back in focus after its second quarter 2026 report showed higher revenue than a year ago and a narrower net loss, along with updated full year guidance for IBSRELA and XPHOZAH. See our latest analysis for Ardelyx. Despite Ardelyx reporting higher year over year revenue and a narrower net loss, the stock has come under pressure, with the 30 day share price return down 24.24% and the year to date share price return down 34.96%. Even so, the 5 year total shareholder return of...

Iovance Biotherapeutics recently reported its second-quarter 2026 results, with revenue rising to US$99.31 million from US$59.95 million a year earlier and net loss narrowing to US$47.32 million from US$111.66 million, while also maintaining full-year 2026 revenue guidance of US$350 million to US$370 million. For the first half of 2026, the company lifted revenue to US$170.74 million and reduced net loss to US$126.36 million versus the prior year, highlighting improving operating performance...

Microvast Holdings slipped about 1.3% to US$0.86 today, yet that small move barely hints at the pressure inside the latest earnings print. Q2 revenue came in at US$87.3m with a sharp drop in adjusted earnings before interest, tax, depreciation and amortisation, and a GAAP net loss of US$12.0m. For a high capital intensity battery manufacturer, the real headline is margin compression. Gross margin narrowed to 29.5%, while operating expenses climbed, raising fresh questions about how...

Why Morgan Stanley stock is back in focus after new bond offerings Morgan Stanley (MS) has returned to investors' watchlists after a cluster of fixed income activities, including newly announced fixed coupon notes and several recently completed medium term note offerings across different maturities. See our latest analysis for Morgan Stanley. At around $215 per share, Morgan Stanley has eased in the short term, with a 30 day share price return down 3.24% and a 7 day return down 0.91%...

Kaspi.kz came into this print with the stock already on a steady upward grind, up around 8% over the past three months, and it added another 1.4% today. That is a calm reaction for a fintech and e commerce platform that just posted quarterly revenue of 1,112,152m KZT and net income of 258,889m KZT. The real headline is profit power holding up as Kaspi.kz leans into transaction growth. Basic earnings per share of 1,362.38 KZT kept the earnings story intact, even as investors focus on how that...

Exponent (EXPO) drew investor attention after raising its full year and third quarter 2026 revenue growth guidance, while also reporting higher second quarter sales, revenue and net income, and confirming both its dividend and expanded share repurchase program. See our latest analysis for Exponent. The recent guidance upgrade and confirmed capital return plans appear to have improved sentiment around Exponent, with a 30-day share price return of 10.06% and a 90-day share price return of...

In the past quarter, Grand Canyon Education, Inc. reported higher net income of US$45.85 million and diluted EPS of US$1.75 for the second quarter and raised its full‑year 2026 earnings guidance, while also confirming it has repurchased 22,616,124 shares under its long-running buyback program. An interesting angle for investors is how management’s latest guidance for full‑year diluted EPS of US$9.93–US$10.07 now frames expectations against the company’s long-term service revenue model and...

What is driving interest in AAR (AIR) right now Recent coverage highlighting AAR (AIR) as a momentum stock pick, supported by positive earnings estimate revisions and a favorable Zacks Rank, has drawn fresh attention to the company and its recent share performance. See our latest analysis for AAR. AAR's recent move to a US$145.45 share price comes after a 35.34% 3 month share price return and a 72.23% year to date share price return. The 1 year total shareholder return of 86.45% points to...

The story with Hims & Hers Health today is the gap between the selloff and the scoreboard. The stock slipped about 4% to US$30.55 after earnings, even though Q2 revenue landed at US$753m and adjusted earnings before interest, tax, depreciation and amortization reached US$60m. That tension between a red screen and a growing telehealth platform is what matters for you as an investor. Heading into the print, Hims & Hers Health had rallied sharply over the past three months, then cooled over the...

Freedom Holding stock has more than doubled over the past five years, yet the current valuation checks suggest the shares may not offer obvious value at today’s price. With the company expanding its banking and digital ecosystem in markets such as Turkiye, investors are weighing that growth story against signals that the stock leans expensive. Freedom Holding has returned about 139.1% over the past five years, which puts recent price weakness into context as a longer term gain that investors...

What Hubbell’s latest earnings and guidance tell investors Hubbell (HUBB) reported second quarter and six month 2026 results on July 28, alongside full year guidance for sales and GAAP diluted earnings per share that gives investors fresh data to assess the stock. The company reported second quarter sales of US$1,711.8 million compared with US$1,484.3 million a year earlier, while net income was US$240.4 million compared with US$244.2 million. Diluted earnings per share from continuing...

InTest stock has been grinding lower over the past three months, yet it inched up 1.1% to close at US$13.36 after the Q2 print. That small bounce hides a more complicated story. Revenue landed at US$35.3m with adjusted earnings per share of US$0.09, while management lifted full year sales guidance to a range of US$135m to US$140m. For a company that only recently shifted back into profitability, this quarter is less about a single beat or miss and more about whether investors trust that...

In the second quarter of 2026, Corcept Therapeutics reported net income of US$42.99 million, up from US$35.15 million a year earlier, with higher basic and diluted earnings per share, while six-month net income fell to US$11.23 million from US$55.70 million. Alongside completing a multi-year US$188.58 million share repurchase program, the company raised its 2026 revenue guidance to US$1.10–1.20 billions, signaling management’s confidence in the underlying business. With Corcept now...

Ferguson Enterprises stock was riding a solid 30 day gain coming into this earnings print. The shares then dropped about 4.7% today. That is a sharp reset for a distributor that many investors view as a steady compounder in plumbing, HVAC and infrastructure. The headline is simple: earnings held up better than the price reaction suggests. Revenue reached about US$8.8b in the quarter and diluted earnings per share came in around US$3.39. Trailing 12 month earnings of just over US$10 per share...

Kinder Morgan recently joined Phillips 66 and HF Sinclair in announcing a joint venture to develop the Western Gateway Pipeline system, expanding its role in transporting energy products across key North American corridors. This collaboration highlights how Kinder Morgan can use its extensive infrastructure and strong free cash flow to pursue capital projects alongside industry peers. We’ll now examine how Kinder Morgan’s Western Gateway Pipeline joint venture could influence its investment...

UnitedHealth Group just delivered a punchy earnings headline while the stock quietly slipped. Shares closed at US$402.20, down about 1.6% on the day and modestly weaker over the past month, even as quarterly adjusted earnings per share landed at US$6.38 and operating earnings rose sharply compared with a year ago. The market looks more cautious than the numbers alone might suggest. Investors seem to be discounting the earnings strength and raised full year guidance, and instead leaning into...